The Tweed Hospital
Tweed Heads, New South Wales, Australia
General hospital in Tweed Heads, New South Wales
Powell St & Florence Street, Tweed Heads NSW 2485
About The Tweed Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
5
Australasian Gastro-Intestinal Trials Group
4
ETOP IBCSG Partners Foundation
3
University of Sydney
3
BeiGene
2
Daiichi Sankyo, Inc.
2
Hoffmann-La Roche
2
Keros Therapeutics, Inc.
2
Morphotek
2
AVEO Pharmaceuticals, Inc.
1
Arcus Biosciences, Inc.
1
Clinical Trials at The Tweed Hospital
During the past decade, The Tweed Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 19 clinical trials were completed, i.e. on
average, 95% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
2000-11-01
2016-08-01
Completed
1,086
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
2005-09-01
2013-03-01
Completed
303
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
2005-06-01
2007-07-01
Completed
333
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
2007-08-01
2009-06-01
Terminated
630
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
2008-12-01
2026-06-01
Active, not recruiting
1,587
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Tweed Hospital" #1 sponsor was "Pfizer" with 5 trials, followed by "Australasian Gastro-Intestinal Trials Group" with 4 trials
sponsored, "ETOP IBCSG Partners Foundation" with 3 trials sponsored, "University of Sydney" with 3 trials sponsored and "BeiGene"
with 3 trials sponsored. Other sponsors include 20 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Tweed Hospital"
#1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator. Other collaborators include 41 different institutions and companies that were
collaborators in the rest 46 trials.
Clinical Trials Conditions at The Tweed Hospital
According to Clinical.Site data, the most researched conditions in "The Tweed Hospital" are
"Breast Cancer" (6 trials), "Breast Neoplasms" (2 trials), "Cancer of the Prostate" (2 trials), "Colorectal Cancer" (2 trials) and "Gastro-Oesophageal Cancer" (2 trials). Many other conditions were trialed in "The Tweed Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The Tweed Hospital
Most popular intervention types in "The Tweed Hospital" are "Drug" (38 trials), "Biological" (6 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Paclitaxel" (5 trials), "Enzalutamide" (4 trials), "Carboplatin" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Tweed Hospital
The vast majority of trials in "The Tweed Hospital" are
32 trials for "All" genders, 6 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at The Tweed Hospital
Currently, there are NaN active trials in "The Tweed Hospital".
undefined are not yet recruiting,
8 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 17 completed trials in The Tweed Hospital,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Tweed Hospital, 1 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".